Adimmune Corporation
15 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Dose-finding Study for AdimrSC-2f Vaccine (NCT05104489) | Adimmune Corporation | 2022-01-03 |
| A Study to Evaluate the Safety and Immunogenicity of COVID-19 (AdimrSC-2f) Vaccine (NCT04522089) | Adimmune Corporation | 2020-08-24 |
Track Adimmune Corporation automatically
Every clearance here is in the API, with alerts when new ones post.